article thumbnail

SparkRx: The first digital therapeutic for adolescents

pharmaphorum

SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols. “In In primary care, there are guidelines to screening for behavioural health concerns like depression annually. About the author .

article thumbnail

Sanofi forges $30m alliance with digital health firm DarioHealth

pharmaphorum

Originally set up with a focus on diabetes, Dario has added capabilities in hypertension, weight management, and musculoskeletal and behavioural health in the intervening years, for example by acquiring musculoskeletal wearable company Upright Technologies and digital behavioural health specialist wayForward last year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Clinical trials get more and more digitalised.

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. The book notes pharma can utilise VR for clinical trials as it allows for a better understanding of the research subject.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. They also understand how to do clinical trial design,” Gani states.

article thumbnail

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

pharmaphorum

grant, administered by OhioMHAS, and part of the US Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) SOR grant programme for people in need of prevention, treatment and recovery support for opioid use disorder. Funding is provided by the State Opioid Response (SOR) 2.0

article thumbnail

FDA green lights Oxehealth vital signs monitoring software

pharmaphorum

In a clinical trial, the software was found to be accurate to within three beats per minute for pulse rate compared to contact pulse oximeters, and two breaths per minute for estimated breathing rate. million people, as well as assisted living facilities, general hospitals, behavioural health providers and custodial care settings.

Nurses 59